From what I can gather from a recent news article on Bidens tardiness regarding appointing his FDA head (only an interim at present), MSB is not being aided by the fact a new FDA boss is not sitting there making any informed and difficult decisions about anything.
As per:
"Across the federal government, there are more than 400 positions requiring Senate confirmation for which Biden has yet to put forward nominees, including the heads of the Food and Drug Administration, Customs and Border Protection and the Office of Management and Budget.
The jobs are being filled temporarily by officials limited by their acting capacity: They are unlikely to appoint the permanent staff below them or to make any structural or cultural changes.
Even once nominations are made, it can take months for nominees to make it through the confirmation process and into their permanent roles — meaning a number of agencies and departments may have no permanent leaders through the summer.
"It's the equivalent of having a substitute teacher. They could be an amazing educator, but everyone knows the substitute teacher doesn't get respect from the classroom, and they don't see themselves as owning the long-term education of the class," said Max Stier, president of the Partnership for Public Service, a nonprofit good government group.
"As a result, they are unlikely to take on the big hairy problems or things that require a long time to resolve, and people on the outside are unlikely to receive them as having much authority, certainly not long-term authority."
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-8918
-
- There are more pages in this discussion • 9,380 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B |
Open | High | Low | Value | Volume |
$1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 26808 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 16001 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 26808 | 1.440 |
2 | 28628 | 1.435 |
8 | 68533 | 1.430 |
5 | 155422 | 1.425 |
4 | 32112 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.445 | 16001 | 1 |
1.450 | 4515 | 1 |
1.455 | 6500 | 1 |
1.460 | 45215 | 3 |
1.465 | 36008 | 2 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online